Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
By backing founders, we're building capability in the critical technologies — from engineering biology to quantum — that drive economic growth and create the high-skilled jobs of the next decade.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities. Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.




.webp)

Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is now ready to take new tenants.
We currently welcome applications from service providers working in legal, IT, grants, cloud, bespoke software and marketing.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.



Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, engineering biology and advanced materials — the UK government's designated frontier industries.
Deep Tech can revolutionise entire industries, create high-skilled jobs and unlock new economic growth while improving lives.
We specialise in Deep Tech because the social, environmental and economic returns are proportional to the ambition. It demands patient capital and deep technical understanding, and that's exactly what we're built to provide.

Cambridge RNA Technologies is developing long-term RNAs (ltRNAs) - engineered RNA molecules that persist for weeks or months rather than hours. By combining the safety of RNA with durability previously only achievable through genome modification, ltRNAs enable durable therapeutic gene expression for protein replacement, immune cell engineering, and regenerative medicine without the risks of permanent genomic changes.

Bitrobius Genetics is transforming the treatment of genetic diseases by intercellular transmission of DNA. Its Gentrafix™ platform technology overcomes a major challenge in gene therapy - ensuring therapeutic genes reach the majority of cells in an affected area - by generating plasmids that can replicate, spread and carry genes within human cells. This paves the way for more cost-effective manufacturing of potential cures, addressing the limited number of gene therapies currently available on the market, which are among the most expensive medicines in history.

Tolemy Bio is enabling the future of cell and gene therapy with precision-designed custom media solutions. Using artificial intelligence, machine learning and data-driven insights, it designs and manufactures tailored cell culture media to enhance specific therapy production and accelerate R&D timelines. Its approach enhances cell growth, improves yields and drives better outcomes for next-generation therapies, from discovery to clinical development.



Our versatile spaces can welcome a variety of events, from small meetings to 60-person seminars including catering and a fully licensed bar.
